These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12065874)

  • 1. Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.
    Vlaykova T; Talve L; Hahka-Kemppinen M; Hernberg M; Muhonen T; Collan Y; Pyrhönen S
    Oncology; 2002; 62(3):259-68. PubMed ID: 12065874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
    Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
    Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.
    Nikkola J; Vihinen P; Vlaykova T; Hahka-Kemppinen M; Heino J; Pyrhönen S
    Melanoma Res; 2004 Feb; 14(1):29-37. PubMed ID: 15091191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma.
    Vlaykova T; Talve L; Hahka-Kemppinen M; Hernberg M; Muhonen T; Franssila K; Collan Y; Pyrhönen S
    Oncology; 1999 Oct; 57(3):242-52. PubMed ID: 10545794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of beta1 integrin expression in metastatic melanoma.
    Vihinen P; Nikkola J; Vlaykova T; Hahka-Kemppinen M; Talve L; Heino J; Pyrhönen S
    Melanoma Res; 2000 Jun; 10(3):243-51. PubMed ID: 10890378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of biomarkers in malignant melanoma.
    Hernberg M; Turunen JP; von Boguslawsky K; Muhonen T; Pyrhönen S
    Melanoma Res; 1998 Jun; 8(3):283-91. PubMed ID: 9664152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
    Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
    J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-2 protein expression in melanocytic neoplasms of the skin.
    Ramsay JA; From L; Kahn HJ
    Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study.
    Espíndola MB; Corleta OC
    World J Surg Oncol; 2008 Jun; 6():65. PubMed ID: 18570663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors.
    Sparrow LE; English DR; Taran JM; Heenan PJ
    Am J Dermatopathol; 1998 Feb; 20(1):12-6. PubMed ID: 9504663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
    Böni R; Doguoglu A; Burg G; Müller B; Dummer R
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings.
    Tchernev G; Orfanos CE
    J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
    Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R
    Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.